ASCO 2024: Improved progression-free survival in PD-L1-positive hormone receptor-positive, HER2-negative breast cancer
In patients with metastatic hormone receptor (HR)-positive/HER2-negative breast cancer unselected by PD-L1 status, adding the…
Browsing: ASCO
ASCO 2024: Drug targeting protein involved in control of immune response produces encouraging results in glioblastoma
A drug that targets a protein involved in regulating the immune response might be promising…
ASCO 2024: Experimental therapy shows promise in pancreatic cancer clinical trial
Clinicians at Georgetown University’s Lombardi Comprehensive Cancer Center, USA, reported promising preliminary findings based on…
ASCO 2024: New ‘Armoured’ CAR produces significant responses in patients whose cancers don’t respond to current CAR T cell therapies
While CAR T cell therapy has revolutionised treatment for many blood cancers, including non-Hodgkin lymphoma (NHL), many…
ASCO 2024: Trial reveals benefits of ‘stepped’ palliative care for patients with advanced lung cancer
A new study led by investigators from Mass General Cancer Center, USA, reveals the effectiveness…
ASCO 2024: Immunotherapy significantly increases the number of patients free from bowel cancer
An immunotherapy drug given before surgery instead of chemotherapy meant that over ten times more…
ASCO 2024: Telehealth can significantly reduce greenhouse gas emissions associated with cancer care, study finds
Telemedicine visits for cancer care may not only be more convenient and easier to schedule…
ASCO 2024: Promising results from the first clinical trial of an innovative next-generation antibody in patients with advanced solid tumours, especially in melanoma
Initial data from the first phase 1 trial of the bispecific antibody FS222 demonstrate that…
ASCO 2024: Spanish-language content for lung cancer patients helps break down barriers to care
Estelamari Rodriguez, M.D., M.P.H., is the recipient of the Patient Educator of the Year award…
ASCO 2024: Research group completes first trial of Black patients with early-stage breast cancer
Black patients with early-stage breast cancer who were treated with docetaxel chemotherapy every 3 weeks…